Complications in Hypertension and Obesity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-12-31

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Hypertension Obesity Dyslipidemia Hyperglycemia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

metabolic syndrome hypertension obesity dyslipidemia hyperglycemia cardiovascular complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age older 18 years
* Signed informed consent
* Blood pressure more than 130 and/or 85 mm Hg
* Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2
* Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level)
* Fasting glucose more than 5,6 mmol/l

Exclusion Criteria

* Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus)
* Severe concomitant diseases affecting outcome

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Conrady Alexandra

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eugene V Shlyakhto

Role: STUDY_DIRECTOR

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Almazov Federal Center of Heart, Blood and Endocrinology

Saint Petersburg, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexandra O Conrady, MD, PhD

Role: CONTACT

Phone: +7812-70255-71

Email: [email protected]

Elena I Baranova, professor